Meet the EUCROF26 Programme Committee
EUCROF is delighted to introduce the minds that are carefully curating this year’s programme. With combined expertise that spans across Europe and from each corner of the Clinical Research landscape, the EUCROF26 Programme Committee will construct the conference’s agenda to portray a perfect snapshot of the current state of European Clinical Research, as well as discussing critical issues arsing in the sector.
With breakout streams that covered AI, DCTs, Regulatory Considerations, Paediatrics, Medical Devices, and more, EUCROF25’s Programme captured key ideas in clinical research in 2025. This year’s abstracts promise updated, cutting-edge ideas on topics that are paramount to our industry.
Meet the people putting in the work to showcase innovation at EUCROF26.
Programme Committee Co-Chairs
Doris Neuhauser, PSI CRO
Doris Neuhauser is a seasoned clinical research and pharmaceutical professional with over 25 years of experience in leading the development and execution of clinical trials across various therapeutic areas and European markets. She has proven expertise in managing Phase I–III trials, with a strong focus on oncology, neuroscience, immunology, infectious diseases, inflammatory bowel disease (IBD), and rare diseases. For the past six years, Doris has been serving as Country Head for Austria at PSI CRO, a global full-service contract research organization. In this role, she is responsible for full operational oversight, including resource allocation, budgeting, trial delivery, and regulatory compliance. She also acts as the primary liaison to executive leadership, regulatory authorities, and key stakeholders.
Marcello Milano, BioMarin
Marcello Milano is a director in the R&D and Regulatory Policy team at BioMarin, a global biotechnology company that develops innovative therapies for rare genetic diseases. In his role, Marcello focuses on EU regulatory intelligence, regulatory policy development and advocacy as a member of working groups across industry organizations, including EuropaBio, EUCOPE, ARM, MPP and BIA. Amongst other roles, he acts as EUCOPE alternate in the Accelerating Clinical Trials in Europe (ACT-EU) Multistakeholder Platform Advisory Group.
Marcello has been part of the biopharmaceutical industry for about 30 years, of which nearly 20 in the regulatory affairs field, with previous roles in Chiesi and GSK. He holds a chemistry degree from the University of Padua, It
Programme Committee
Browse the EUCROF25 Programme
The EUCROF25 programme aimed to further enrich the dialogue and cooperation across the spectrum of clinical research sectors. Sessions reflected the current state of clinical research while also exploring the pressing challenges and exciting opportunities that lie ahead.